2003-2004 Review of Anticoagulants, Thrombolytics and Anti-platelet Drugs 4 October 2015 8:06 PM.

Slides:



Advertisements
Similar presentations
Drugs and Coagulation at Point-of-Care
Advertisements

Anticoagulants, anti-platelet & fibrinolytics
Drugs for Coagulation Disorders Andrew N. Schmelz, PharmD Post-Doctoral Teaching Fellow Purdue University October 8, 2008
Chapter 19 Agents Affecting Blood Clotting. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Blood.
Anticoagulant, Antiplatelet, and Thrombolytic Drugs
ANTICOAGULANTS AND THROMBOLYTIC AGENTS ANTICOAGULANTS AND THROMBOLYTIC AGENTS.
Drugs influencing coagulation Dr Sanjeewani Fonseka Department of Pharmacology.
Vascular Pharmacology
Current Thoughts on Anticoagulants and Regional Anesthesia Terry C. Wicks, CRNA, MHS Catawba Valley Medical Center Hickory, North Carolina.
Antiplatelet Drugs (Anti-thrombotics)
Dalia Elfawy., MD Lecturer of Anesthesia and ICU Ain Shams University 2014 RAPID REVERSAL OF ANTICOAGULATION IN TRAUMA PATIENTS.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 28 Coagulation Modifier Drugs.
Anticoagulant, Fibrinolytic and Antiplatelet
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 53 Management of ST-Elevation Myocardial Infarction.
Drugs used in coagulation disorders By S.Bohlooli, Ph.D.
Hematopoiesis Pharmacology Review 28 August :22 AM.
Anticoagulant, Antiplatelet, and Thrombolytic Drugs
ANTICOAGULANT, THROMBOLYTICS & ANTIPLATELET DRUGS.
Nov 21 st, 2011 Jaehyung (Gus) Cho, Ph.D. Assistant Professor Department of Pharmacology Tel: (Office: 5095 CoMRB)
Drugs that affect hemostasis Ahmad Shihada Silmi Msc, FIBMS IUG Faculty of Sciences Medical Technology Dep.
Antiplatelet Drugs - Principles Benedict R. Lucchesi, M.D., Ph.D. Department of Pharmacology University of Michigan Medical School.
Drugs for Coagulation disorders. There are a number of different categories of drugs which modify the coagulation process: I. Anticoagulants II. Antiplatelet.
Drug used in disorders of coagulation
ANTIPLATELET DRUGS.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 27 Coagulation Modifier Drugs.
Review of Anticoagulants, Thrombolytics and Anti-platelet Drugs 3 November :19 AM.
ASPIRIN ↓ Cox inhibition ↓ (PROSTACYCLIN) PGI 2 & TXA 2 (THROMBOXANE) LOW DOSE ASPIRIN.
Oral Anticoagulant Drugs Spoiled sweet clover caused hemorrhage in cattle(1930s). Spoiled sweet clover caused hemorrhage in cattle(1930s). Substance identified.
THROMBOLYTIC DRUGS (Fibrinolytic drugs) By Prof. Hanan Hagar.
ANTIPLATELET DRUGS Learning objectives By the end of this lecture, students should be able to: - describe different classes of anti-platelet drugs and.
Antiplatelet drugs Prof. Hanan Hagar Learning objectives By the end of this lecture, students should be able to to describe different classes of anti-platelet.
Blood Vessel Injury IX IXa XI XIa X Xa XII XIIa Tissue Injury Tissue Factor Thromboplastin VIIa VII X Prothrombin Thrombin Fibrinogen Fribrin monomer.
Antiplatelet drugs Dr.V.V.Gouripur. Antiplatelet drug An antiplatelet drug is a member of a class of drugs that decreases platelet aggregation and inhibits.
THROMBOLYTIC DRUGS (Fibrinolytic drugs) By Prof. Hanan Hagar
Anticoagulants, Thrombolytic Agents and Antiplatelet Drugs
Anticoagulation Reversal May 11, Objectives Develop an approach for treating patients with iatrogenic coagulopathy Understand recent changes in.
Agents Affecting Blood Clotting
DRUGS FOR BLOOD COAGULATION DISORDERS This study material is recommended specifically for practical courses from Pharmacology II for students of general.
Dr. Laila M. Matalqah Ph.D. Pharmacology
At the end of session students should be able to:  Know the normal hemostatic pathway  Know Parenteral anticoagulant drugs  Know pharmacokinetics,
DRUGS USED IN DISORDERS OF COAGULATION
Antiplatelet drugs Prof. Hanan Hagar Learning objectives By the end of this lecture, students should be able to To describe the role of platelets in.
Prof. Abdulrahman Almotrefi
Anticoagulants, Antiplatelets, and Thrombolytics
Drugs Used in Coagulation Disorders Presented by Dr. Sasan Zaeri PharmD, PhD.
Drugs Used in Coagulation Disorders
Pharmacotherapy Preview Program (P3) Antiplatelet Agents Anticoagulants Thrombolytics Lipid Lowering Medications Brandon Dyson, PharmD, BCPS.
Anticoagulant, Antiplatelet, and Thrombolytic Drugs.
II. Antiplatelet Drugs.
ANTITHROMBOTIC THERAPY
Antithrombics, Anticoagulants & Antiplatelets
Anticoagulants, Antiplatelets, and Thrombolytics
Anticoagulants, Antiplatelets, and Thrombolytics
ANTIPLATELETS AND ANTICOAGULANTS
Regional anesthesia on anticoagulants
Antiplatelets Anticoagulants Drugs Thrombolytics
Management of ST-Elevation Myocardial Infarction
Antithrombotic drugs Fibrinolytics
Med Chem Tutoring for Anticoagulants, Antiplatelets, and Thrombolytics
ANTIPLATELET DRUGS.
Drugs Used in Coagulation Disorders
What is a Blood Clot? 9/18/2018 MEDC 604 Anti-coagulants.
Coagulation Modifier Drugs
Anticoagulants Cooper University Hospital School of Perfusion By:
Drugs affecting blood and blood-forming organs
Anticoagulants.
Prof. Abdulrahman Almotrefi
Antiplatelet Drugs Dr. : Asmaa Fady MD., MSC, M.B, B.Ch
Section B: Science update
Presentation transcript:

Review of Anticoagulants, Thrombolytics and Anti-platelet Drugs 4 October :06 PM

Abciximab Antiplatelet Anti-GPIIb/IIIa receptor antibody

Anistreplase Thrombolytic Streptokinase + plasminogen

Argatroban Anticoagulant Direct thrombin inhibitor

Aspirin (Acetylsalicylic acid, ASA) NSAID (acetylsalicylate) Analgesic, Anti-inflammatory Antipyretic, Antiplatelet Irreversible cyclooxygenase inhibitor

Bivalirudin Anticoagulant Direct thrombin inhibitor

Clopidogrel Antiplatelet ADP receptor antagonist

Dalteparin Anticoagulant LMW Heparin ATIII activator

Dipyridamole Antiplatelet Phosphodiesterase inhibitor (increases cAMP)

Drotrecogin alfa (Activated Protein C) Anticoagulant Many actions Treatment for septic shock

Enoxaparin Anticoagulant LMW Heparin ATIII activator

Eptifibatide Antiplatelet GPIIb/IIIa antagonist

Heparin Anticoagulant ATIII activator

Hirudin Anticoagulant Direct thrombin inhibitor (DTI)

4-Hydroxycoumarin Oral anticoagulant Vitamin K synthesis inhibitor

Lepirudin Anticoagulant Direct thrombin inhibitor (DTI)

Protamine Sulfate Heparin antagonist

Streptokinase Thrombolytic

Ticlopidine Antiplatelet ADP receptor antagonist

Tissue plasminogen activators Thrombolytics alteplase, reteplase, tenecteplase

Urokinase Thrombolytic

Warfarin Anticoagulant Vitamin K synthesis inhibitor

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.